HER2 Targeted Therapies

(2:50)

Sequencing HER2-targeted therapies in breast cancer

(59)

Study of Targeted Therapy for HER2-Positive Metastatic Breast Cancer

(3:19)

HER2-Targeted Therapy in Early Stage HER2+ Breast Cancer

(7:41)

Dr. Brufsky Discusses Resistance to HER2-Targeted Therapies

(2:33)

Dr. Hamilton on Overcoming Resistance to HER2-Targeted Therapy in Breast Cancer

(1:13)

Advances in HER2-targeted therapies for gastric cancer

(3:12)

Dr. Hurvitz on How to Navigate HER2-Targeted Therapy in Breast Cancer

(1:37)

Ask the expert: Early-stage HER2-positive breast cancer with Adrienne Waks, MD

(1:5:11)

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and Toxicity

(20:17)

What is HER2 Positive Breast Cancer? | Treatment/Therapies for HER2 positive Breast Cancer

(4:11)

Anti-HER2 Mechanisms of Approved HER2 Inhibitors

(5:5)

HER2-Low Breast Cancer: DESTINY or Good Science?

(11:12)

Estrogen Receptors \u0026 HER2/neu Receptors in Breast Cancer (a TUTORIAL from Oster Oncology)

(21:19)

Cardio Effects of Herceptin in HER2 Breast Cancer

(36:37)

The Science of HER2-low Breast Cancer and Implications for the Pathology Team

(54:43)

HER2-Positive Breast Cancer: The Evolving Treatment Landscape

(5:45)

Targeted Therapy Vs Chemotherapy | Targeted Therapy For Cancer- Dr. Sreenivass BJ | Doctors' Circle

(1:48)

Advances in Breast \u0026 Gynaecological Cancer Management - 21 Feb

(1:30:39)

#17. Can HER2 testing (and HER2 targeted therapies) help you?

(3:53)

Introduction and Overview of HER2-Targeted Therapies in Breast Cancer

(7:52)

JACC: CardioOncology Video Case Presentation: Cardiotoxicity During HER2-Targeted Therapy

(40:4)

Use of HER2-Targeted Therapy in Breast Cancer

(5:46)

Targeted Therapy for HER2-positive Breast Cancer Animation

(1:26)

How do we treat GEJ carcinoma resistant to HER2 targeted therapies?

(1:15)

Evolving role of HER2 targeted therapies in gastroesophageal cancers

(10:8)

HER2-Targeted Therapy in Early Breast Cancer

(5:28)

HER2-targeted Therapy: Routes of Administration

(15:16)

Evolving Landscape of HER2-Targeted Therapy in Breast Cancer

(3:45)

Dr. Tripathy on Determining the Best HER2 Targeted Therapy

(1:6)